Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

US Patent 11535611 · Granted Dec 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compoun2025
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof2024
LRRK2 inhibitors2024
Leucine-rich repeat kinase 2 (LRRK2) inhibitors2024
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023
Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines2023